Recently many potential protein biomarkers have been reported in the literature for the diagnosis of AML e.g. ApoE, complement factor H, HPT, apolipoprotein A-N, SAA1, and gelsolin using proteomics techniques28–31. The gene discussed is SAA1; the disease is acute myeloid leukemia.